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B-1a cells acquire their unique characteristics by
bypassing the pre-BCR selection stage
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B-1a cells are long-lived, self-renewing innate-like B cells that predominantly inhabit the
peritoneal and pleural cavities. In contrast to conventional B-2 cells, B-1a cells have a receptor
repertoire that is biased towards bacterial and self-antigens, promoting a rapid response to
infection and clearing of apoptotic cells. Although B-1a cells are known to primarily originate
from fetal tissues, the mechanisms by which they arise has been a topic of debate for many
years. Here we show that in the fetal liver versus bone marrow environment, reduced IL-7R/
STAT5 levels promote immunoglobulin kappa gene recombination at the early pro-B cell stage.
As a result, differentiating B cells can directly generate a mature B cell receptor (BCR) and
bypass the requirement for a pre-BCR and pairing with surrogate light chain. This ‘alternate
pathway’ of development enables the production of B cells with self-reactive, skewed spe-
cificity receptors that are peculiar to the B-1a compartment. Together our findings connect
seemingly opposing lineage and selection models of B-1a cell development and explain how
these cells acquire their unique properties.
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B-CLL is the most common form of adult leukemia in thewestern world1. In the early 1980s, the T-cell antigen CD5(Ly-1) was identified on the surface of cancerous B cells in
patients with B-CLL2,3. This observation led to the search for
normal CD5+ B-cell counterparts to potentially determine the
cancer cell of origin. As a result of these efforts, CD5+ B cells,
otherwise known as B-1a cells, were discovered in mice4,5. Fur-
ther characterization of CD5+ B-1a B cells revealed that they are
long-lived, self-renewing cells that predominantly reside in the
pleural and peritoneal cavities where they produce natural poly-
reactive IgM antibodies with a biased, autoreactive repertoire. In
contrast to conventional B-2 cells, B-1a cells produce antibodies
with reduced junctional diversity and less somatic hypermuta-
tion6. Furthermore, Igh VH gene rearrangements favor
VH12 segment usage7, generating antibodies that interact with
phosphatidylcholine (PtC), a major lipid in the protective mucus
layer of the gastrointestinal tract that is also present in the
membranes of diverse bacteria. Thus, the B-1a receptor repertoire
is biased toward bacterial and self-antigens, which is important
for mounting a rapid immune response to infection and in the
clearing of apoptotic cells8–10. Because B-1a cells are found in
pre-immune mice, they function as an important first line of
defense against bacterial pathogens. These characteristics distin-
guish B-1a cells from conventional B-2 cells, which have a highly
diverse receptor repertoire that is important for mediating
adaptive immunity.
Although B-1a cells were discovered in the early 1990s, their
origin has been hotly debated since, and despite the efforts of
numerous labs this remains an unresolved issue. The controversy
has mainly been centered on two opposing models, the lineage
model and the selection model. The lineage model proposes that a
distinct B-1 progenitor cell gives rise to B-1a cells, while the
selection model favors the idea that a common B-cell progenitor
can acquire a B-1a or a B-2 fate depending on the type of antigen
it recognizes9,11. Support for the lineage model comes from early
reconstitution experiments, which reveal that fetal tissues are
much more efficient at generating B-1a cells in irradiated reci-
pient mice than adult bone marrow counterparts12. Furthermore,
the first wave of B-1a cells was shown to originate in early
embryos in an HSC-independent manner13–17. However, cellular
barcoding experiments demonstrate that a single progenitor cell
can give rise to both B-1a and B-2 cells18 challenging the notion
that B-1a cells arise from a distinct lineage. Moreover, the finding
that B-1a cells have a restricted and biased receptor repertoire
provides support for a selection model9,19. Further support for
the selection model comes from a study by Graf et al. that made
use of a transgenic system to show that swapping B-2 and B-1a-
specific B-cell receptors (BCRs) is sufficient to efficiently change a
B-2 cell into a B-1a cell in the absence of any lineage constraints.
The lineage switch is rapid, induces a proliferative burst, and cells
migrate to their normal environments within the pleural and
peritoneal cavities20.
Investigations have also focused on expression of specific genes
that influence development. For example, the Lin28b/let7 mole-
cular switch influences CD5+ B-1a cell fate21–23. The Lin28b and
let7 miRNAs, respectively, promote and inhibit the expression of
the transcription factor, Arid3a, which in turn can drive the
development of CD5+ B-1a cells22,23. Nonetheless, the BCR
repertoire of the resulting cells do not include PtC-specific anti-
bodies that are characteristic of a typical B-1a cell compartment22.
Thus, enforced expression of Arid3a fails to fully explain how B-
1a cells develop. Another transcription factor, BHLHE41 has also
been shown to be important in B-1a cell biology24. Specifically,
cells deficient in this transcription factor lose B-1a cells expressing
VH12/VK4 PtC-specific receptors, have impaired BCR signaling,
increased proliferation, and apoptosis. BHLHE41 therefore plays
an important role in B-1a maintenance by regulating self-renewal
and BCR repertoire; however, it is not known whether its forced
expression can drive development of these cells.
In the fetus, B-cell development takes place in the liver and
moves to the bone marrow after birth. Each stage of development
is marked by a particular rearrangement event that drives dif-
ferentiation forward. These recombination events occur in a
stage-specific manner. The first step involves the joining of the
immunoglobulin heavy-chain (Igh) DH and JH gene segments
within pre-pro-B cells. Rearrangement continues at the pro-B cell
stage, where VH-to-DJH joining is both initiated and completed.
Rearrangement of the immunoglobulin light-chain gene loci, Igk
or Igl, occurs at the subsequent pre-B cell stage of development.
Igh and Igk gene rearrangement is separated by a proliferative
burst of large pre-B cells that allows individual cells that have
successfully rearranged their heavy chain to clonally expand. At
the following small pre-B cell stage, each B-cell undergoes a
distinct Igk gene recombination event25. Ultimately, this results in
unique heavy- and light-chain pairs that expand the antigen
receptor repertoire. The successful pairing of immunoglobulin
heavy chain with surrogate light chain (SLC) forms the pre-B cell
receptor (pre-BCR), which is required for expansion of large pre-
B cells and subsequent differentiation to the small pre-B cell stage,
where Igk recombination occurs. Since SLC pairs poorly with
autoreactive heavy chains, the pre-BCR provides a mechanism for
negative selection of self-reactive B cells26,27.
As noted early on, B-1 cell development is quantitatively
unaffected in SLC-deficient mice, and in a small fraction of B-cell
progenitors in the bone marrow Igk rearrangements occur prior
to rearrangements at Igh and independent of SLCs28–31. In
addition, in the absence of SLC and thus pre-BCR expression, an
autoreactive BCR can drive B-cell development efficiently to the
stage of the immature B cell, where BCR diversification and
counterselection of autoreactivity is achieved through the process
of receptor editing. This has led to a model in which early B-cell
development is driven by a positive signal from the pre-BCR (in
the majority of progenitors) or an autoreactive BCR (in a min-
ority of cells), with the pre-BCR having evolved as a surrogate
autoreactive BCR32,33.
Downstream of pre-BCR signaling, IL-7 receptor (IL-7R) sig-
naling is extinguished at the small pre-B cell stage. This is
noteworthy because the IL-7R signaling pathway is responsible
for directing the sequential ordering of recombination events, i.e.,
heavy-chain gene followed by light-chain gene rearrangement in
classical B-cell development34,35. IL-7 is a cytokine secreted by
stromal cells within the bone marrow where development takes
place throughout the postnatal and adult life of the animal. In
murine bone marrow, development past the pre-pro-B cell stage
stringently requires IL-7R36,37. In contrast, B-cell development
within the fetal liver can occur independent of IL-738,39. In terms
of directing recombination, IL-7 and its downstream signaling
component STAT5 have been shown to promote Igh accessibility
and recombination40–42 while actively inhibiting recombination
of the Igk locus34,43. Activated STAT5 enters the nucleus and
forms a complex with PRC2/EZH2, which binds to the intronic
enhancer of Igk (iEκ) and induces H3K27me3-mediated repres-
sion to inhibit recombination of this locus44,45. Strikingly, con-
ditional deletion of STAT5 within pro-B cells results in a robust
increase of Igk recombination at the pro-B cell stage35.
It is known that B-1a cells originate primarily from fetal tissues,
however, it remains unclear what pathways drive B-1a cell
development and lead to the acquisition of their unique char-
acteristics. In addition, it has been shown that B-1a cells are
efficiently generated in Il7−/− and Il7r−/− mice albeit at reduced
numbers compared with wild-type38,39,46,47. Given our finding
that fetal liver (FL) pro-B cells have less active cytoplasmic
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pSTAT5 than bone marrow (BM) pro-B cells48, we asked
whether this could influence V(D)J recombination and B-cell
development.
Here, we show that low levels of IL-7R/pSTAT5 signaling in
the fetal liver environment promote an “alternate pathway” of B-
cell development, in which increased Igk rearrangement occurs at
the pro-B cell stage of development. Productive rearrangement of
Igh and Igk at this stage leads directly to cell surface expression of
a mature BCR, bypassing the requirement for SLC and the
selection of autoreactive receptors that are characteristic of B-1a
cells. Extending earlier work, we demonstrate that while SLC-
independent development leads to a significant reduction in B-2
cell numbers, B-1a cells with their characteristic VH12 anti-PtC
bias are still efficiently generated. Thus, reduced IL-7R/
STAT5 signaling promotes an alternate pathway of development
which favors the production of B-1a cells with self-reactive
receptors characteristic of this B-cell subset. Together these data
connect opposing lineage and selection models of B-1a cell
development and explain how these cells acquire their unique
properties.
Results
Igk recombination is increased in fetal liver pro-B cells. Fetal
liver (FL) and bone marrow (BM)-derived progenitor cells are
differentially dependent on IL-7 for development, and we have
found that FL-derived pro-B cells have significantly lower levels
of the downstream signaling component, phospho-STAT5 com-
pared with their bone marrow-derived pro-B cell counterparts48.
Thus, we asked whether alterations in phospho-STAT5 levels
correlate with altered regulation of Igk recombination in these
two anatomic locations. To explore this, we analyzed recombi-
nation from ex vivo-derived bone marrow (5–6 wk adults) and FL
(E17–18) pro-B cells using semiquantitative PCR analysis
(Fig. 1a). This assay uses a degenerate Vκ primer with a common
reverse primer downstream of Jκ gene segments to measure
recombination of a Vκ with each of the four Jκ segments49. As
shown in Fig. 1a, FL pro-B cells have increased Igk recombination
relative to BM pro-B cells.
To address the question of altered Igk recombination between
these two cell types in a more quantitative manner, we made use
of a real-time PCR assay that quantifies Jκ1 rearrangement by
assessing the retention of germline Igk50. In this assay, a product
cannot be generated after recombination, because the sequence to
which the upstream primer binds is lost or inverted during the
recombination process. Quantitation of the amplified product is
determined as a ratio between the single copy gene β-actin and
the germline Igk band. Control tail DNA, in which no Igk
rearrangement occurs, is set at 100%. Consistent with the
semiquantitative experiments described above, FL pro-B cells
have lower levels of Igk germline retention (61%) relative to bone
marrow pro-B cells (87%) (Fig. 1b).
To determine the proportion of cells that are actively
undergoing recombination at a single-cell level, we used three-
dimensional (3-D) immunofluorescent in situ hybridization
(FISH) assay that visualizes recombination by the association of
γ-H2AX DNA repair foci with the individual alleles of antigen
receptor loci51,52. In these experiments, we used two Igk BAC
DNA probes that hybridize to the distal Vκ24 (RP23–101G13)
gene region and the Cκ region (RP24–387E13) in combination
with an antibody against the phosphorylated form of γ-H2AX
(Fig. 1c). We found significantly increased association of γ-H2AX
foci with the Igk locus in FL versus bone marrow-derived pro-B
cells (16.7% versus 3.0%). Consistent with our previous experi-
ments, the frequency of DNA breaks in FL pro-B cells (16.7%) is
again at an intermediate level compared with BM pre-B cells
(30%) where Igk recombination typically occurs (Fig. 1d). These
numbers reflect the combined data from two independent
experiments (Supplementary Table 1).
It is known that activated STAT5 forms a complex with PRC2
and binds to the intronic enhancer of Igk, iEκ to inhibit Igk
recombination44,45,48. To determine if the increase in early Igk
rearrangement could be caused by reduced STAT5-mediated
repression, we analyzed enrichment of STAT5 binding on iEκ via
STAT5-ChIP-qPCR. As shown in Fig. 1e, we found that FL pro-B
cells have significantly less STAT5 bound to iEκ compared with
BM pro-B cells, and binding levels more closely resemble those in
BM pre-B cells where Igk recombination normally occurs. Taken
together, these findings indicate that in the FL versus BM
environment, Igk rearrangement occurs at higher levels in pro-B
cells due to a decrease in STAT5-mediated repression of the
Igk locus.
Antigen receptor loci undergo large-scale contraction through
chromatin looping, which enables rearrangement between widely
dispersed gene segments. Locus contraction is tightly linked both
to recombination status and usage of distal gene segments49,53.
To address the contraction status of the Igk locus, we measured
the distance separating the distal Vκ24 and Cκ probes in
interphase cells. Our analyses indicate that FL pro-B cells are
significantly more contracted than wild-type (WT) double-
positive (DP) T cells, a cell type in which Igk rearrangement
does not occur (Fig. 2). Indeed, the level of contraction is
comparable with that seen in wild-type bone marrow-derived
pre-B cells, where Igk gene rearrangement is known to occur.
Bypass of the pre-BCR checkpoint. Classical bone marrow B-cell
development starts with Igh recombination at the pre-pro to pro-B
cell stages followed by Igk/Igl recombination at the small pre-B cell
stage. However, JHT mice that lack JH segments as well as the Igh
intronic enhancer, and are therefore unable to undergo Igh
recombination, but can rearrange Igk/Igl independent of Igh
rearrangement (Fig. 3a)29,54,55. This is also true for SLC-deficient
mice, and a fraction of B cells undergoing development in the bone
marrow of wild-type mice56. Given our finding that a significant
number of pro-B cells rearrange Igk in the FL environment, we
reasoned that productive heavy and light-chain gene rearrange-
ment in pro-B cells could lead to expression of a mature BCR,
bypassing the requirement for a pre-BCR. To address this question
as a proof of principle, we examined FL B cells from mice that are
deficient for a component of SLC, lambda5 (Igll1−/−), in con-
junction with a transgene that has a prearranged functional heavy
chain (B1.8). Igll1−/−mice display a strong developmental block at
the pro-B cell stage and made very few IgM+ cells (0.59% of B
cells). In contrast Igll1−/−, B1.8 and B1.8 mice produce similarly
high percentages of IgM+ B cells (12 and 13.5%, respectively).
Importantly, B1.8 mice have a substantial pre-B cell compartment
which is not observed in Igll1−/−, B1.8 mice despite a similar
output of IgM+ B cells which express IgK protein (Fig. 3b). This
shows that having a productive heavy- and light chain can bypass
the requirement for pairing with SLC to form immature B cells
that express the mature BCR. Together these data demonstrate that
in the FL, expression of Igh and Igk at the pro-B cell stage can
bypass the developmental block induced by surrogate light-chain
deficiency by forming B cells with a mature BCR.
B-1a cells are efficiently generated in Igll1−/− mice. B-1a cells
are primarily generated from fetal tissues, and we have shown
that FL-derived B cells frequently undergo early Igk recombina-
tion allowing cells to bypass the pre-BCR selection stage. Thus,
we next asked whether an absence of SLC could impact the
generation of B-1a cells12,23. Here, we analyzed the B-2 as well as
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the B-1 compartment, which consists of both B-1a and B-1b cells.
B-1b cells are distinct from B-1a cells in that they lack CD5
expression and have a memory function in protecting against
bacterial infections57. As expected, peritoneal B-2 cells were sig-
nificantly decreased compared with controls. Furthermore,
although B-1b cells were also significantly decreased, the B-1a cell
compartment remained intact. This was reflected in cell
percentage, as well as total cell numbers (Fig. 4a, b). These data
indicate that while B2 and B1b cell development is strongly
promoted by SLC, B-1a cells do not depend on a pre-BCR
checkpoint. It should be noted that B1.8 transgenic mice could
not be used to analyze the B-1a cell compartment in SLC-
deficient mice, because the B1.8 pre-rearranged heavy chain does
not support B-1a cell development58.
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Two different subsets of B-1a cells that segregate different
functions of the B-1a cell compartment have been identified by
the plasma cell alloantigen 1 (PC1)59,60. PC1lo B-1a cells produce
higher amounts of natural IgM, and can undergo plasma cell
differentiation, while PChi B-1a cells produce less natural IgM,
have PtC-reactive BCRs, and can produce IL-10. In order to
determine whether or not both of these subsets of B-1a cells were
represented in B-1a cells generated in SLC-deficient mice, we
analyzed PC1 expression. B-1a cells from Igll1−/− mice were
found to have similar proportions of PC1lo and PC1hi B-1a cells
as in wild-type mice (Fig. 4c). This suggests that not only is the B-
1a compartment size normal in SLC knockout mice but also the
PC1lo and PC1hi subsets are maintained.
B1-a cells cannot be detected in FL, and first appear in the
transitional B-cell population 1 week after birth61,62. To further
analyze the impact of surrogate light-chain deficiency on the
generation of B1a cells, we examined transitional B-1a cells in
spleens from 10–11 days old neonatal mice. As expected, the
proportion of B-2 in cells in this population was severely reduced,
while the proportion of B-1a cells was found to increase. This is
reflected by the finding that total numbers of transitional B-2 cells
are severely depleted compared with B1a cells in Igll1−/− versus
wild-type mice (Fig. 5a–c). Thus, even at this early stage of life,
transitional B-1a cells from SLC-deficient mice are found at only
moderately reduced levels compared with their wild-type
counterparts, indicating that the presence of adult Igll1−/− B-1a
cells is not a result of clonal expansion by self-renewal over time.
B-1a cell development is inhibited in Stat5b-CA mice. Our data
suggest that low phospho-STAT5 signaling induces early Igk
recombination in FL pro-B cells, which promotes the efficient
generation of B-1a cells in SLC-deficient mice. To further validate
the role of IL-7R/STAT5 signaling in B-1a cell development, we
next asked whether increased STAT5 signaling could have the
opposite effect on B-1a cell development and impair the genera-
tion of this compartment. To address this question, we used mice
expressing a constitutive active form of STAT5 (Stat5b-CA)63.
In these mice, we found that although B-2 and B-1b cell
development were not significantly affected, all three independent
littermate controlled Stat5b-CA mice exhibited a decrease in the
B-1a cell compartment. This is reflected in cell proportions as well
as the total cell numbers (Fig. 6a, b). Thus, STAT5 signaling
inhibits B-1a cell development underscoring the importance of
Fig. 1 Early Igk recombination is increased in the fetal liver versus bone marrow pro-B cells. a Semiquantitative PCR performed on ex vivo-derived BM pro-B
(CD19+B220+IgM−CD25−CD117+) from 6-week-old mice and FL pro-B (Lin−CD19+B220+IgM−CD2−CD117+) from E17.5 mice to assess rearrangement
of Vκ to each functional Jκ. Each lane represents threefold serial dilutions of input DNA. DNA levels were normalized to Aicda levels, which is located on
the same chromosome as Igk. b Recombination with Jκ1 was quantified by qPCR using primers specific for the unrearranged germline sequence. DNA is
quantified as a ratio between the single copy β-actin gene and the Igk germline PCR product and shown as a proportion of tail DNA. Schematics outline
primer-binding sites on the Igk locus (bottom of a, b). Error bars represent the standard deviation (n= 4 biologically independent samples for tail and FL
pro-B cells n= 5 biologically independent samples for BM pre-B (CD19+B220+IgM−CD117+CD25+) and BM pro-B). P-values were calculated using two-
tailed T tests. c 3-D immuno-DNA FISH was performed on ex vivo sorted B cells using BAC probes specific to the distal Vκ24 (RP23–101G13) gene region
and the Cκ region (RP24–387E13), shown in red and green, respectively, in conjunction with an antibody to the phosphorylated form of γ-H2AX in white.
Representative images of a B cell with no γ-H2AX associated with Igk alleles (top) and with γ-H2AX associated with one Igk allele (bottom). Scale bar= 1
μm. d Percentage of B cells (BM pro-B, BM pre-B, and FL pro-B) with at least one Igk allele associated with a γ-H2AX focus. Error bars represent standard
deviation (n= 2 biologically independent samples). P-values were calculated using two-tailed Fisher’s exact tests. e STAT5-ChIP-qPCR of iEκ on ex vivo
sorted cells. The data are represented as a proportion of input DNA, and error bars represent the standard deviation (n= 3 biologically independent
samples). For all P-values, *significant (0.05–0.01), **very significant (0.01–0.001), ***highly significant (<0.001). For b, d, and e, source data are provided
as Source Data File
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Fig. 2 The Igk locus is similarly contracted in FL pro-B cells and BM pre-B cells. a Representative confocal microscopy images showing the distance
separation between the probes on Igk in fetal liver pro-B cells (Lin−CD19+B220+IgM−CD2−CD117+), bone marrow pre-B cells (CD19+B220+IgM−
CD117+CD25+), and double-positive T cells (CD90.2+TCRB−CD4+CD8+). b Distances separating the two ends of the locus are displayed as a cumulative
frequency curve. A left shift on the curve is indicative of closer association. Bone marrow pre-B cells (blue), fetal liver pro-B cells (green), and negative
control double-positive T cells (black). P-values were generated using two-sample Kolmogorov–Smirnov tests (n= 2 independent experiments)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12824-z ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4768 | https://doi.org/10.1038/s41467-019-12824-z | www.nature.com/naturecommunications 5
reduced IL-7R/STAT5 signaling in driving the development of
these cells.
B-1a cells Igll1−/− mice express PtC-specific receptors. B-1a
cells are known to have a strong bias for immunoglobulin rear-
rangements that confer specificity to PtC (VH12/VK4). In addi-
tion, the pre-BCR is known to select against B-1a-specific
autoreactive heavy chains as a result of a defect in pairing of the
latter with SLC26,27. Given these facts, we next asked whether B-
1a cells that develop independent of SLC would promote the
generation of B-1a-specific rearrangements. To address this
question, we analyzed peritoneal cavity B cells for VH12 usage
and specificity against PtC. As shown in Fig. 6c, B-1a cells from
Igll1−/− mice express VH12 rearranged receptors. Importantly,
these VH12+ B-1a cells bind PtC containing liposomes, inferring
WT FL Pro-B JHT FL Pro-B
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Fig. 3 Early Igk rearrangement enables B cells to bypass the pre-BCR checkpoint. a Igk recombination can occur independent of Igh recombination as shown
by semiquantitative PCR performed on ex vivo-derived fetal liver pro-B cells E17.5 (Lin−CD19+B220+IgM−CD2−CD117+) from wild-type and JHT mice.
Each lane represents threefold serial dilutions of input DNA. DNA levels were normalized to iEκ b Representative flow-cytometry plots of fetal liver E17.5
cells from Igll1−/−, B1.8, and Igll1−/−;B1.8 littermates (from top to the bottom). Pro-B and pre-B cell gates are displayed as a percentage of CD19+IgM−
cells (left), IgM+ are displayed as a percentage of CD19+ cells (middle), and IgK+ histograms are displayed as a percentage of CD19+IgM+ cells (right)
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that they have the canonical VH12/VK4 gene segment bias
(Fig. 6c). In addition, there is not a significant difference in the
proportion of B-1a cells that have specificity against PtC (Fig. 6d).
Thus, an absence of SLC supports the generation of these self-
reactive B-1a cells.
Igll1−/− and wild-type B-1a cells have similar repertoires. To
determine how SLC deficiency affects gene segment usage, we
sequenced the BCR repertoires of B-1a cells from WT and SLC-
deficient mice. Briefly, peritoneal cavity B-1a cells were sorted,
lysed, and the rearranged Igh products amplified by PCR. Illu-
mina adapters and barcodes were added, and the rearrangements
sequenced by next-generation sequencing. BCR repertoires were
analyzed by IMGT/High-V-QUEST, and visualized using IMGT/
StatClonotype64–67. These analyses revealed that B-1a cells from
Igll1−/− mice have a similar overall VH usage compared with
those of wild-type mice (Fig. 7). This shows that B-1a cells that
develop in the absence of SLC have a wide distribution of gene
segment usage, and thus do not represent a clonal expansion of a
few rare progenitors. A diverse repertoire was also observed for
light-chain gene segment usage (Fig. 8). As expected, VH12
(VH12-3) usage was found to be high in wild-type B-1a cells, and
calculated proportions were comparable with our flow-cytometry
experiments in the cells from Igll1−/− mice (Fig. 6c)7. VK4, which
pairs with VH12 to confer PtC specificity, has a reduced repre-
sentation in SLC-deficient B-1a cells, but it is still found at sig-
nificantly higher frequency than in wild-type B-2 cells (Fig. 8).
These rearrangement studies support the data from our flow-
cytometry analysis and underscore the finding that B-1a cells
generated in the absence of SLC maintain a VH12/VK4 gene
segment bias.
To confirm that B-1a cells generated in SLC-deficient mice
were from fetal origin, we analyzed Igh sequence for N-additions.
B-1a cells are known to predominately come from fetal origins
and as a consequence of low Tdt activity at this stage, they are
known to have reduced N-additions compared with adult bone
marrow-derived B cells. Our analysis revealed that Igll1−/−
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peritoneal cavity B-1a cells had similarly reduced levels of N-
additions as wild-type controls (Fig. 9). The paucity of N-
additions supports the idea that B-1a cells are efficiently
generated in SLC-deficient mice, maintaining key B-1a cell traits
like VH12 and VK4 gene segment bias and reduced levels of
junctional diversity.
Discussion
Although it was known that B-1a cells predominantly develop in
the FL, the pathways driving development and the mechanisms
underlying the generation of B cells with a repertoire skewed
toward autoreactivity were not previously known. Indeed, this has
been a subject of debate for many years. Here, we now reveal that
a reduction in IL-7 signaling in the FL environment alleviates Igk
repression and promotes early rearrangement of this locus in pro-
B cells. Productive heavy and light-chain gene rearrangement at
the pro-B cell stage can lead directly to the expression of a mature
BCR, thereby bypassing the requirement for a pre-BCR check-
point. Since PtC-specific VH gene rearrangements pair poorly
with SLC26 and the pre-BCR selects against autoreactive recep-
tors27, SLC-independent development provides an explanation
for how B cells with autoreactive, PtC-specific receptors are
generated. In more general terms and along Jerne’s idea that the
immune system selects antibody mutants from an initial self-
reactive repertoire68, B-cell progenitors can be initially positively
selected by the expression of autoreactive BCRs or their evolu-
tionary surrogate, the pre-BCR32,33. This is followed by negative
selection of autoreactivity through receptor editing. The skewing
of the B-1a receptor repertoire toward autoreactivity likely reflects
the imprint of the initial positive selection of B-1a cells through
autoreactive BCRs rather than SLC (Fig. 10).
The idea that B-1 cells can develop in a SLC-independent
manner is not novel. In fact, Kitamura et al. observed that in
contrast to B-2 cells, B-1 cells were essentially unaffected by SLC
deficiency, however, the distinct effect on the B-1a versus B-1b
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cell compartment was not investigated28. Our analyses demon-
strate that while B-2 and B-1b cell development is severely
impaired in Igll1−/− mice, B-1a cells can be generated at wild-
type levels. Furthermore, SLC-independent B-1a development can
occur through a mechanism that involves reduced IL-7R/
STAT5 signaling and early Igk rearrangement. We found that B-
1a cell development is selectively impaired in Stat5b-CA mice,
providing additional support for the idea that SLC-independent
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B-1a cell development is favored by a decrease in IL-7 signaling. It
should be noted that although Igk rearrangement can occur prior
to Igh rearrangement, it is not a prerequisite for SLC-independent
B-1a cell development. Indeed, a rearranged Igh that cannot
associate with SLC could persist at the pro-B cell stage until
subsequent productive Igk rearrangement generates a BCR
independent of IGH-SLC pairing. Taken together, our findings
point to a model in which B-1a cells typically develop in a SLC-
independent manner. Interestingly, earlier work analyzing
expression patterns of genes relevant to rearrangement in the yolk
sac, para-aortic splanchnopleura, and spleen demonstrates that at
E9–11, early lymphoid progenitor cells express Rag2 and VpreB,
but lack expression of Igll169. The delayed expression of the SLC
component, lambda5 (Igll1), points to the possibility that there is
an early window in which B-cell development can occur in the
absence of SLC. This stage coincides with the stage at which the
earliest B-1 progenitor cells are detected (E9 in the yolk sac and
para-aortic splanchnopleura)70,71. Thus, we speculate that the
reason why early progenitors become B-1 cells is because they
develop in a SLC-independent manner. The observation that
SLC-deficient mice generate B-1a cells with autoreactive receptors
supports this model27. The generation of SLC-independent
autoreactive receptors does not need to occur at high fre-
quency, because cells that acquire a B1a cell receptor undergo a
rapid proliferative burst and thus even a few cells have the ability
to give rise to a robust B1a cell population20. In sum, assignment
of a SLC-independent pathway of B-cell development to B-1a
cells provides a new perspective on B-1a development, reconciling
old lineage and selection models (Fig. 10).
Methods
Mice. Igll1−/− (Jackson Laboratory 002401) and Stat5b-CA mice were maintained
on a C57BL/6 background, as previously described28,36,72. B1.8 mice73 were crossed
onto a Igll1−/− background. These mice were housed and cared for in accordance
with IACUC guidelines and protocols approved by NYUMC (protocol #: IA15-
01468) and U of Minnesota (protocol #: 1502–32347A).
Flow cytometry and antibodies. BM and FL cell populations were isolated from
C57Bl/6 mice via cell sorting and analyzed by flow cytometry. B- and T-cell anti-
bodies include: anti-CD45R/B220 (clone: RA3–6B2 cat. no. 553092), anti-CD19
(clone 1D3 cat. no. 557655), anti-IgMb (clone AF6–78 cat. no. 553520), anti-IgM
(clone II/41 cat. no. 553437, 743324), anti-IgK (clone 187.1 cat. no. 562476, 562888),
anti-CD117/c-Kit (clone 2B8 cat. no. 553356), anti-CD2 (clone RM2–5 cat. no.
553111), anti-CD25/IL2RA (clone PC61 cat. no. 553866), anti- CD93 (clone AA4.1
cat. no. 561990) anti-CD90.2/Thy1.2 (clone 53–2.1 cat. no. 25-0902-82), anti-CD5
(clone 53-7.3 cat. no. 553022), anti-VH12 (clone 5C5)74 anti-TCRB (clone H57–597
cat. no. 47-5961-82), anti-CD8a (clone 53-6.7 cat. no. 553031), anti-CD4 (clone
RM4-5 cat. no. 553051), anti-ENPP1/PC1 (clone YE1/19.1 cat. no. 149207). All of
Pr
op
or
tio
n 
of
 c
el
ls
Number of N-additions 
0.8
0.6
0.4
0.2
0
1.0
0 5 10 15
WT PerC B-1a
WT BM immature B
Igll1–/– PerC B-1a
Fig. 9 Wild-type and Igll1−/− peritoneal cavity B-1a cells have similar low
levels of N-additions as compared with wild-type counterparts. Cumulative
frequency graph demonstrates the proportion of cells that have a certain
number of N-additions between VH and VD gene segments for wild-type
peritoneal cavity B-1a cells CD19+B220loCD5+ (blue), Igll1−/− peritoneal
cavity B-1a CD19+B220loCD5+ cells (green), and wild-type bone marrow
immature B cells CD19+ B220+ IgMint (black) (n= 2 independent
experiments)
B-1a cellPro-B
Pro-B Large pre-B Small pre-B Immature IgM+B cell
Classical
B-2 cell
Igh/Igk
Igh Igk
Classical B cell development
(favored in bone marrow)
Alternate B cell development
(favored in fetal liver)
High pSTAT5
Low pSTAT5
(SLC)
Receptor editingPre-BCR positive selection
Autoreactive BCR 
positive selection Immature 
IgM+B cell
Fig. 10 The model of classical versus alternate B-cell development. The classical B-cell developmental pathway is favored in the bone marrow where high
levels of STAT5 signaling inhibit Igk recombination at the pro-B cell stage. At the large pre-B cell stage, a productive heavy-chain pairs with SLC and pre-
BCR signaling at this stage leads to proliferative expansion and positive selection. Autoreactive heavy-chains pair poorly with SLC, and will not experience
positive selection in this manner. Following Igk recombination (blue) at the small pre-B cell stage, self-reactive B cells can undergo receptor editing to
further select against self-reactive BCRs. The alternate B-cell developmental pathway is favored in fetal liver where low levels of STAT5 signaling in pro-B
cells promotes Igk recombination at the same stage as Igh recombination (blue). This enables the generation of B cells expressing a mature BCR instead of
a pre-BCR. Here, self-reactive B cells are initially positively selected by self-antigens. Although these B cells can potentially undergo receptor editing to
modify their BCRs, the initial positive selection of autoreactive B cells skews the B-1a BCR repertoire toward autoreactivity
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12824-z
12 NATURE COMMUNICATIONS |         (2019) 10:4768 | https://doi.org/10.1038/s41467-019-12824-z | www.nature.com/naturecommunications
the antibodies were obtained from BD Pharmigen, except anti-CD90.2, anti-TCRB,
and anti-ENPP1/PC1 (eBioscience). Fluorescent DPOC/CHOL liposomes were
acquired from FormuMax. The gating strategy was as follows: bone marrow pro-B
cells B220+/CD19+/IgM−/c-kit+/CD25−/IgM−, BM pre-B cells B220+/CD19+/
IgM−/c-kit−/CD25+, FL pro-B cells (E17.5) B220+/CD19+/IgM−/c-kit+/CD2−,
and thymic DP cells Thy1.2+/TCRB−/CD19−/CD4+/CD8+. FL pro-B cells were
sorted on CD2− instead of CD25−, because CD25 is not expressed in fetal B cells.
CD2 expression is correlated with cytoplasmic μ heavy chain, and can be used to
identify pre-B cells and efficiently sort pro-B cells from the FL75. From the peritoneal
cavity, B-2, B-1a, and B-1b were identified as followed: B-2 cells B220hi/CD19+,
B-1a cells B220lo/CD19+/CD5+, and B-1b cells B220lo/CD19+/CD5−. To obtain FL
precursor cells, FLs from E15.5–17.5 were subject to lineage depletion using the
following biotin-labeled antibodies: anti-CD4 (RM4–5), anti-CD8a (53-6.7), anti-
TCRγδ, anti-CD49b (DX5), anti-Ly6G/Ly6C (RB6-8C5), anti-CD11c (N418), anti-
CD11b (M1/70), anti-F4/80 (BM8), anti-Ter-119 (TER-119) followed by a negative
selection using streptavidin magnetic rapidspheres (STEMCELL Technologies). The
remaining cells were sorted as: Lin−/CD19−/IgM−/c-kit+/CD2−/B220lo. Cells were
sorted using a FACSAria I (BD). The data were also collected on an LSR II (BD) and
analyzed using FlowJo software.
Intracellular staining for IgK. FL E17.5 B cells were stained for surface markers
(CD19, B220, IgM, IgK, CD2, and CD127), followed by permeabilization/fixation
and secondary staining for IgM and IgK in accordance with the manufacturer’s
instructions (BD 554714). Antibodies with different conjugated flourophores were
used to distinguish between surface IgM/IgK (BD 554714 and 562476) and
intracellular IgM/IgK (BD 553437 and 562888).
Semiquantitative Igk rearrangement. DNA was prepared from sorted cells by
proteinase K digestion at 55 C for 4 h, 85 C for 10 min. VκJκ joints were amplified
using a degenerate Vκ primer (5′-GGCTGCAGSTTCAGTGGCAGTGGRTCWG-
GRAC-3′), and a Jκ5 primer (5′-ATGCCACGTCAACTGATAATGAGCCCTC
TCC-3′). Acidia gene was amplified as a loading control (AID F: 5′-GCCACCTT
CGCAACAAGTCT-3′, AID R: 5′-CCGGGCACAGTCATAGCAC-3′). Bands were
run through a 1.5% agarose gel electrophoresis and imaged using a ChemiDoc XR
+ (Bio-Rad). Germline retention analysis of Jκ1 was carried out by real-time
quantitative PCR analysis, as previously described50.
Immuno-DNA FISH. Combined detection of γ-H2AX and Igk loci was carried out
on cells adhered to poly-L lysine-coated coverslips, as previously described51. Cells
were fixed with 2% paraformaldehyde/PBS for 10 min, and permeabilized for 5 min
with 0.4% Triton/PBS on ice. After 30 min blocking in 2.5% BSA, 10% normal goat
serum, and 0.1% Tween-20/PBS, H3S10ph staining was carried out using an
antibody against phosphorylated serine-10 of H3 (Millipore) diluted at 1:400 in
blocking solution for 1 h at room temperature. Cells were rinsed three times in
0.2% BSA, 0.1% Tween-20/PBS and incubated for 1 h with goat-anti-rabbit IgG
Alexa 488 or 594 or 633 (Invitrogen). After three rinses in 0.1% Tween-20/PBS,
cells were post fixed in 3% paraformaldehyde/PBS for 10 min, permeabilised in
0.7% Triton-X-100 in 0.1 M HCl for 15 min on ice, and incubated in 0.1 mg/ml
RNase A for 30 min at 37 °C. Cells were then denatured with 1.9 M HCl for 30 min
at room temperature and rinsed with cold PBS. DNA probes were denatured for
5 min at 95 °C, pre-annealed for 45 min at 37 °C, and applied to coverslips which
were sealed onto slides with rubber cement and incubated overnight at 37 °C. Cells
were then rinsed three times 30 min with 2x SSC at 37 °C, 2x SSC, and 1x SSC at
room temperature. Cells were mounted in ProLong Gold (Invitrogen) containing
DAPI to counterstain the total DNA.The Igk locus was detected using BAC DNA
probes that hybridize to the distal Vκ24 gene region (RP23–101G13) and the Cκ
region (RP24–387E13), in combination with an antibody against the phosphory-
lated form of γ-H2AX. BAC probes were directly labeled by nick translation with
dUTP-A594 or dUTP-A488 (Invitrogen). FISH for locus contraction was con-
ducted as previously published51.
Confocal microscopy and analysis. Cells were analyzed by confocal microscopy
on a Leica SP5 Acousto-Optical Beam Splitter system. Optical sections separated by
0.3 μm were collected. Analysis on cells included those in which signals from both
alleles could be detected, which encompassed 90–95% of the total cells imaged.
Further analysis was carried out using ImageJ. Alleles were defined as colocalized
with γ-H2AX if the signals overlapped. Sample sizes typically included a minimum
of 100 cells, and experiments were repeated at least two or three times. Statistical
significance was calculated by χ2 analysis in a pair-wise manner. For locus con-
traction, distances were measured between the center of mass of each BAC signal.
Significant differences in distributions of empirical inter-allelic distances were
determined by a nonparametric two-sample Kolmogorov–Smirnov (KS) test. To
eliminate observer bias, each experiment was analyzed by at least two people.
STAT5-ChIP-qPCR. STAT5-ChIP-qPCR was conducted as previously described44.
Purified DNA was then analyzed by quantitative real-time PCR. Samples were
analyzed in triplicate and represent three biological replicates.
Igh and Igk repertoire analysis. Cells were sorted and lysed in 0.5mg/mL pro-
teinase K at 55 C for 4 h, 85 C 10min. Lysed cells were used as a template for
HotStarTaq (Qiagen) PCR amplification. Igh primers used to amplify rearrange-
ments were adapted from VH FR3 and JH BIOMED-2 primers76,77. Additional
primers were designed to capture some V genes missing from the BIOMED-2 study,
which include VH12 (VH12-3). Igk primers include the degenerate V primer used in
the semiquantitative PCRs with additional primers designed to capture some B-1a
cell-biased gene segments, which include VK4 (VK4–91) (Supplementary Table 2).
Amplified rearrangements were purified by gel extraction (Qiagen) followed by a
standard end-repair reaction. Following purification steps were carried out by
Ampure XP bead purification (Beckman Coulter). In order to attach Illumina-
compatible adapters, samples were treated by standard dA tailing followed by
adapter ligation using Quick Ligase (NEB) mixed with pre-annealed NEXTflex
DNA Barcodes (Bioo Scientific). QC was carried out by tapestation, and quantified
by qPCR (Kapa Biosystems). Samples were pooled and sequenced on an Illumina
HiSeq 4000 (2 × 150 PE reads). Nucleotide sequences were compared with the
reference equences from IMGT, the international ImMunoGeneTics information
system (http://www.imgt.org) and analyzed using IMGT/HighV-QUEST67, a web
portal allowing the analysis of thousands of sequences on IMGT/V-QUEST65.
IMGT/StatClonotype was used to analyze statistically significant gene segment
usage between samples64,66. Igh N-addition information from the region between V
and D gene segments was extracted from IMGT/HighV-QUEST and graphed in R.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support findings of this study have been deposited in the Gene Expression
Omnibus (GEO) database under the accession code GSE104111.
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